In the present study, we developed novel hybrid nanoparticles of CRP polymer and 4F‐angiopep‐2 fusion peptide‐modified liposomes that enable efficient intracerebral Cas9 and sgRNA delivery for glioblastoma therapy. Here, CRP is linked to glioblastoma.